Cargando…

ePCR: an R-package for survival and time-to-event prediction in advanced prostate cancer, applied to real-world patient cohorts

MOTIVATION: Prognostic models are widely used in clinical decision-making, such as risk stratification and tailoring treatment strategies, with the aim to improve patient outcomes while reducing overall healthcare costs. While prognostic models have been adopted into clinical use, benchmarking their...

Descripción completa

Detalles Bibliográficos
Autores principales: Laajala, Teemu D, Murtojärvi, Mika, Virkki, Arho, Aittokallio, Tero
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223370/
https://www.ncbi.nlm.nih.gov/pubmed/29912284
http://dx.doi.org/10.1093/bioinformatics/bty477
_version_ 1783369389793345536
author Laajala, Teemu D
Murtojärvi, Mika
Virkki, Arho
Aittokallio, Tero
author_facet Laajala, Teemu D
Murtojärvi, Mika
Virkki, Arho
Aittokallio, Tero
author_sort Laajala, Teemu D
collection PubMed
description MOTIVATION: Prognostic models are widely used in clinical decision-making, such as risk stratification and tailoring treatment strategies, with the aim to improve patient outcomes while reducing overall healthcare costs. While prognostic models have been adopted into clinical use, benchmarking their performance has been difficult due to lack of open clinical datasets. The recent DREAM 9.5 Prostate Cancer Challenge carried out an extensive benchmarking of prognostic models for metastatic Castration-Resistant Prostate Cancer (mCRPC), based on multiple cohorts of open clinical trial data. RESULTS: We make available an open-source implementation of the top-performing model, ePCR, along with an extended toolbox for its further re-use and development, and demonstrate how to best apply the implemented model to real-world data cohorts of advanced prostate cancer patients. AVAILABILITY AND IMPLEMENTATION: The open-source R-package ePCR and its reference documentation are available at the Central R Archive Network (CRAN): https://CRAN.R-project.org/package=ePCR. R-vignette provides step-by-step examples for the ePCR usage. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
format Online
Article
Text
id pubmed-6223370
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-62233702018-11-14 ePCR: an R-package for survival and time-to-event prediction in advanced prostate cancer, applied to real-world patient cohorts Laajala, Teemu D Murtojärvi, Mika Virkki, Arho Aittokallio, Tero Bioinformatics Applications Notes MOTIVATION: Prognostic models are widely used in clinical decision-making, such as risk stratification and tailoring treatment strategies, with the aim to improve patient outcomes while reducing overall healthcare costs. While prognostic models have been adopted into clinical use, benchmarking their performance has been difficult due to lack of open clinical datasets. The recent DREAM 9.5 Prostate Cancer Challenge carried out an extensive benchmarking of prognostic models for metastatic Castration-Resistant Prostate Cancer (mCRPC), based on multiple cohorts of open clinical trial data. RESULTS: We make available an open-source implementation of the top-performing model, ePCR, along with an extended toolbox for its further re-use and development, and demonstrate how to best apply the implemented model to real-world data cohorts of advanced prostate cancer patients. AVAILABILITY AND IMPLEMENTATION: The open-source R-package ePCR and its reference documentation are available at the Central R Archive Network (CRAN): https://CRAN.R-project.org/package=ePCR. R-vignette provides step-by-step examples for the ePCR usage. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online. Oxford University Press 2018-11-15 2018-06-15 /pmc/articles/PMC6223370/ /pubmed/29912284 http://dx.doi.org/10.1093/bioinformatics/bty477 Text en © The Author(s) 2018. Published by Oxford University Press. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Applications Notes
Laajala, Teemu D
Murtojärvi, Mika
Virkki, Arho
Aittokallio, Tero
ePCR: an R-package for survival and time-to-event prediction in advanced prostate cancer, applied to real-world patient cohorts
title ePCR: an R-package for survival and time-to-event prediction in advanced prostate cancer, applied to real-world patient cohorts
title_full ePCR: an R-package for survival and time-to-event prediction in advanced prostate cancer, applied to real-world patient cohorts
title_fullStr ePCR: an R-package for survival and time-to-event prediction in advanced prostate cancer, applied to real-world patient cohorts
title_full_unstemmed ePCR: an R-package for survival and time-to-event prediction in advanced prostate cancer, applied to real-world patient cohorts
title_short ePCR: an R-package for survival and time-to-event prediction in advanced prostate cancer, applied to real-world patient cohorts
title_sort epcr: an r-package for survival and time-to-event prediction in advanced prostate cancer, applied to real-world patient cohorts
topic Applications Notes
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223370/
https://www.ncbi.nlm.nih.gov/pubmed/29912284
http://dx.doi.org/10.1093/bioinformatics/bty477
work_keys_str_mv AT laajalateemud epcranrpackageforsurvivalandtimetoeventpredictioninadvancedprostatecancerappliedtorealworldpatientcohorts
AT murtojarvimika epcranrpackageforsurvivalandtimetoeventpredictioninadvancedprostatecancerappliedtorealworldpatientcohorts
AT virkkiarho epcranrpackageforsurvivalandtimetoeventpredictioninadvancedprostatecancerappliedtorealworldpatientcohorts
AT aittokalliotero epcranrpackageforsurvivalandtimetoeventpredictioninadvancedprostatecancerappliedtorealworldpatientcohorts